Pure Global

Development and Validation of the Modified Version of VascuQol Scale in Patients With Lower Extremity Peripheral Arterial Disease. - Trial NCT06223217

Access comprehensive clinical trial information for NCT06223217 through Pure Global AI's free database. This phase not specified trial is sponsored by RenJi Hospital and is currently Recruiting. The study focuses on Peripheral Arterial Disease. Target enrollment is 480 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06223217
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT06223217
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Development and Validation of the Modified Version of VascuQol Scale in Patients With Lower Extremity Peripheral Arterial Disease.

Study Focus

Surveys and Questionnaires

Observational

other

Sponsor & Location

RenJi Hospital

Shanghai, China

Timeline & Enrollment

N/A

Oct 01, 2023

Dec 31, 2026

480 participants

Primary Outcome

the Modified version of VascuQol Scale,the Chinese version of VascuQol Scale

Summary

The purpose of this study is to assess the utility of the Modified version of VascuQol Scale
 as an effective biopsychosocial assessment tool for patients suffering from lower extremity
 peripheral arterial disease.

ICD-10 Classifications

Peripheral vascular disease, unspecified
Other peripheral vascular diseases
Other specified peripheral vascular diseases
Peripheral angiopathy in diseases classified elsewhere
Other congenital malformations of peripheral vascular system

Data Source

ClinicalTrials.gov

NCT06223217

Non-Device Trial